Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
2100 participants
OBSERVATIONAL
2016-12-31
2036-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pelvic Cancer Registry for Online Adapted Radiotherapy
NCT06185062
Patient Experience Data in Radiation Oncology
NCT05224297
Neoadjuvant Irradiation of Retroperitoneal Soft Tissue Sarcoma With Ions Retro-Ion
NCT04219202
Registry Study of Proton Radiotherapy in Lymphoma
NCT04613388
Neoadjuvant Irradiation of Extremity Soft Tissue Sarcoma With Ions
NCT04946357
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ion beam therapy
All patients treated with ion beam therapy at MedAustron who consent to the participation in the registry.
Protons and Carbon Ions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Protons and Carbon Ions
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Signed informed consent form
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
EBG MedAustron GmbH
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carola Lütgendorf-Caucig, MD MPH MBA
Role: PRINCIPAL_INVESTIGATOR
EBG MedAustron GmbH
Piero Fossati, MD MSc
Role: PRINCIPAL_INVESTIGATOR
EBG MedAustron GmbH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
EBG MedAustron GmbH
Wiener Neustadt, Lower Austria, Austria
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REGI-MA-002015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.